Valproic acid attenuates Aβ25-35-induced neurotoxicity in PC12 cells through suppression of mitochondria-mediated apoptotic pathway
In conclusion, our results suggested that VPA might serve as a novel protective agent against Aβ25–35-induced cytotoxicity in AD.
Source: Biomedicine and Pharmacotherapy - Category: Drugs & Pharmacology Source Type: research
More News: Alzheimer's | Brain | Drugs & Pharmacology | Mitochondria | Mitochondrial Disease | Neurology | Study